Sangamo Therapeutics
SGMO
#9117
Rank
ยฃ89.94 M
Marketcap
ยฃ0.24
Share price
-6.74%
Change (1 day)
-63.56%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ74.24 Million, an increase over its 2023 earnings that were of -ยฃ89.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million11.93%
2024 -ยฃ74.24 Million-17.27%
2023 -ยฃ89.73 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.7 Million23.17%
2019 -ยฃ79.32 Million36.33%
2018 -ยฃ58.18 Million36.89%
2017 -ยฃ42.51 Million-22.32%
2016 -ยฃ54.72 Million54.86%
2015 -ยฃ35.34 Million75.62%
2014 -ยฃ20.12 Million0.13%
2013 -ยฃ20.1 Million
2011 -ยฃ27.02 Million43.66%
2010 -ยฃ18.81 Million28.52%
2009 -ยฃ14.64 Million-23.55%
2008 -ยฃ19.14 Million2.45%
2007 -ยฃ18.68 Million19.5%
2006 -ยฃ15.64 Million50.78%
2005 -ยฃ10.37 Million75%
2004 -ยฃ5.93 Million-33.25%
2003 -ยฃ8.88 Million-62.27%
2002 -ยฃ23.53 Million102.82%
2001 -ยฃ11.6 Million23.21%
2000 -ยฃ9.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ25.30 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.76 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.17 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.9 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.38 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.90 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.43 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.36 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA